PROLONGATION OF DISEASE-FREE AND OVERALL SURVIVAL WITH THE ADJUVANT FAC-BCG IN STAGE-II, STAGE-III BREAST-CANCER

被引：0
|
作者：
BUZDAR, AU [1 ]
BLUMENSCHEIN, GR [1 ]
GUTTERMAN, JU [1 ]
TASHIMA, CK [1 ]
HORTOBAGYI, GN [1 ]
SMITH, TL [1 ]
HERSH, EM [1 ]
FREIREICH, EJ [1 ]
GEHAN, EA [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [1] THE CORRELATION BETWEEN HORMONAL ADJUVANT THERAPY AND DISEASE-FREE SURVIVAL IN STAGE-II BREAST-CANCER
    GAGLIA, P
    VOLTERRANI, P
    CALDAROLA, B
    LAI, M
    [J]. ANTICANCER RESEARCH, 1986, 6 (03) : 398 - 398
  • [2] ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN STAGE-II OR STAGE-III BREAST-CANCER 5-YEAR RESULTS
    BUZDAR, AU
    BLUMENSCHEIN, GR
    LEGHA, SS
    HORTOBAGYI, GN
    YAP, HY
    SMITH, TL
    HERSH, EM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 144 - 144
  • [3] ADJUVANT CHEMOTHERAPY FOR STAGE-II AND STAGE-III BREAST-CARCINOMA
    CAPRINI, JA
    OVIEDO, MA
    CUNNINGHAM, MP
    COHEN, E
    TRUEHEART, RS
    KHANDEKAR, JD
    SCANLON, EF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (03): : 243 - 246
  • [4] INFLUENCE OF CELLULAR DNA CONTENT ON DISEASE-FREE SURVIVAL OF STAGE-II BREAST-CANCER PATIENTS
    HEDLEY, DW
    RUGG, CA
    NG, ABP
    TAYLOR, IW
    [J]. CANCER RESEARCH, 1984, 44 (11) : 5395 - 5398
  • [5] NON-INVASIVE CARDIAC EVALUATION OF PATIENTS RECEIVING ADRIAMYCIN-CONTAINING ADJUVANT CHEMOTHERAPY (FAC) FOR STAGE-II OR STAGE-III BREAST-CANCER
    ALI, MK
    BUZDAR, AU
    EWER, MS
    CHENG, RS
    HAYNIE, TP
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1983, 23 (03) : 212 - 216
  • [6] Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
    R L Aft
    M Naughton
    K Trinkaus
    K Weilbaecher
    [J]. British Journal of Cancer, 2012, 107 : 7 - 11
  • [7] Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
    Aft, R. L.
    Naughton, M.
    Trinkaus, K.
    Weilbaecher, K.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 7 - 11
  • [8] THE ROLE OF SERUM CEA AS A PROGNOSTIC INDICATOR IN STAGE-II AND STAGE-III BREAST-CANCER PATIENTS TREATED WITH ADJUVANT CHEMOTHERAPY
    THERIAULT, RL
    HORTOBAGYI, GN
    FRITSCHE, HA
    FRYE, D
    MARTINEZ, R
    BUZDAR, AU
    [J]. CANCER, 1989, 63 (05) : 828 - 835
  • [9] ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    RIVKIN, S
    GLUCKSBERG, H
    RASMUSSEN, S
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 353 - 353
  • [10] ADJUVANT THERAPY OF STAGE-II BREAST-CANCER
    CARBONE, PP
    [J]. CANCER, 1990, 65 (09) : 2148 - 2154
12345